M. Davidson

1.3k total citations
28 papers, 932 citations indexed

About

M. Davidson is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Davidson has authored 28 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Davidson's work include Schizophrenia research and treatment (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Occupational and environmental lung diseases (3 papers). M. Davidson is often cited by papers focused on Schizophrenia research and treatment (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Occupational and environmental lung diseases (3 papers). M. Davidson collaborates with scholars based in Australia, United States and United Kingdom. M. Davidson's co-authors include Belinda E. Clarke, Adi F. Gazdar, Kwun M. Fong, Ian A. Yang, Rayleen Bowman, Keith L. Davis, Vahram Haroutunian, Claudia Schmauss, Edwina Duhig and Casey M. Wright and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

M. Davidson

25 papers receiving 911 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Davidson Australia 14 409 281 222 162 105 28 932
Jingbo Li China 16 495 1.2× 379 1.3× 300 1.4× 188 1.2× 110 1.0× 39 1.4k
Lixi Li China 17 305 0.7× 167 0.6× 155 0.7× 82 0.5× 263 2.5× 79 1.0k
Hideyuki Matsushima Japan 15 190 0.5× 75 0.3× 49 0.2× 99 0.6× 143 1.4× 64 729
Kosuke Endo Japan 18 426 1.0× 162 0.6× 151 0.7× 248 1.5× 60 0.6× 45 971
John A. Schoenhard United States 15 222 0.5× 72 0.3× 194 0.9× 84 0.5× 46 0.4× 17 814
R. W. Alexander United States 11 404 1.0× 165 0.6× 66 0.3× 222 1.4× 45 0.4× 16 1.4k
Junhyung Kim South Korea 14 321 0.8× 265 0.9× 171 0.8× 165 1.0× 59 0.6× 49 896
Zhihua Wang China 18 530 1.3× 229 0.8× 192 0.9× 133 0.8× 118 1.1× 70 1.1k
Yuanjian Huang China 18 348 0.9× 92 0.3× 187 0.8× 74 0.5× 110 1.0× 45 771

Countries citing papers authored by M. Davidson

Since Specialization
Citations

This map shows the geographic impact of M. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Davidson more than expected).

Fields of papers citing papers by M. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Davidson. The network helps show where M. Davidson may publish in the future.

Co-authorship network of co-authors of M. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of M. Davidson. A scholar is included among the top collaborators of M. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Davidson. M. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wong, Yee Weng, et al.. (2021). Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors. The Journal of Heart and Lung Transplantation. 40(4). S195–S196. 3 indexed citations
3.
Rabbie, Roy, Peter M. Ferguson, Kim Wong, et al.. (2020). The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. British Journal of Cancer. 124(1). 156–160. 28 indexed citations
4.
Oey, Harald, Marissa Daniels, Vandana Relan, et al.. (2019). Whole-genome sequencing of human malignant mesothelioma tumours and cell lines. Carcinogenesis. 40(6). 724–734. 20 indexed citations
5.
Stroes, Erik S.G., et al.. (2016). Omega-3 carboxylic acids in severe hypertriglyceridemia: EVOLVE II study results. Atherosclerosis. 252. e232–e232. 1 indexed citations
6.
Francis, Santiyagu M. Savarimuthu, M. Davidson, Maxine E. Tan, et al.. (2014). MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression. BMC Genomics. 15(1). 88–88. 69 indexed citations
7.
Wright, Casey M., Santiyagu M. Savarimuthu Francis, Maxine E. Tan, et al.. (2012). MS4A1 Dysregulation in Asbestos-Related Lung Squamous Cell Carcinoma Is Due to CD20 Stromal Lymphocyte Expression. PLoS ONE. 7(4). e34943–e34943. 21 indexed citations
8.
Yang, Ian A., Vandana Relan, Casey M. Wright, et al.. (2011). Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opinion on Therapeutic Targets. 15(4). 439–456. 74 indexed citations
9.
Davidson, M., Jill E. Larsen, Ian A. Yang, et al.. (2010). MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma. PLoS ONE. 5(9). e12560–e12560. 94 indexed citations
10.
Wright, Casey M., Jill E. Larsen, Nicholas K. Hayward, et al.. (2010). ADAM28: A potential oncogene involved in asbestos‐related lung adenocarcinomas. Genes Chromosomes and Cancer. 49(8). 688–698. 19 indexed citations
11.
Bowman, Rayleen, Casey M. Wright, M. Davidson, et al.. (2009). Epigenomic targets for the treatment of respiratory disease. Expert Opinion on Therapeutic Targets. 13(6). 625–640. 26 indexed citations
12.
Davidson, M., Donald B. Hunninghake, T. A. Olson, J. Donovan, & Steven K. Burke. (2000). Colesevelam HCl (Welchol™), a new, potent, well tolerated, non systemic, lipid lowering agent. Atherosclerosis. 151(1). 130–130. 7 indexed citations
13.
Bakker‐Arkema, Rebecca, Linda Shurzinske, M. Davidson, et al.. (1997). 2.P.15 Two-year comparison of safety and efficacy of atorvastatin and lovastatin. Atherosclerosis. 134(1-2). 119–119. 1 indexed citations
14.
Davidson, M., I Matsumoto, B. C. Shanley, & Peter A. Wilce. (1996). FOS and JUN as markers for ethanol-sensitive pathways in the rat brain. Brain Research Bulletin. 39(3). 177–184. 19 indexed citations
15.
Harvey, Philip D., Peter Powchik, Richard C. Mohs, & M. Davidson. (1995). Memory functions in geriatric chronic schizophrenic patients: a neuropsychological study. Journal of Neuropsychiatry. 7(2). 207–212. 9 indexed citations
16.
Davidson, M., et al.. (1993). Chronic ethanol administration sensitizes hippocampal neurons to neurotoxicity of N-methyl-D-aspartic acid.. PubMed. 2. 365–9. 3 indexed citations
17.
Schmauss, Claudia, Vahram Haroutunian, Keith L. Davis, & M. Davidson. (1993). Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.. Proceedings of the National Academy of Sciences. 90(19). 8942–8946. 122 indexed citations
18.
Davidson, M., et al.. (1987). Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.. PubMed. 23(3). 407–10. 3 indexed citations
19.
Leijten, Lonneke, et al.. (1987). Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse uterine epithelial cells. Biochemical Journal. 241(1). 279–284. 1 indexed citations
20.
Gregg, Ronald G., M. Davidson, & Peter A. Wilce. (1986). Cholesterol synthesis and hmg coa reductase activity during hepatocarcinogenesis in rats. International Journal of Biochemistry. 18(4). 389–393. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026